Biogen Inc., 10% Owner at SANGAMO THERAPEUTICS, INC (SGMO), sold 500,000 shares at $5.33 ($2.7M) on 2022-08-29, disclosed to the SEC on 2022-08-31.
Open-market sale of $2.7M SGMO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.33 | 400,000 | $2.1M | 80.2% |
| 2 | $5.27 | 100,000 | $527K | 19.8% |
| Total | $5.32 avg | 500,000 | $2.7M | 100% |
| Filing → |
| SGMO | SELL | 2021-12-28 | $1.4M | — | Filing → |
| SGMO | SELL | 2021-12-10 | $405K | — | Filing → |
| SGMO | SELL | 2021-12-09 | $2.2M | — | Filing → |